HERO Dr Thavorn Group
Selected Publications
Papers in refereed journals: (N=306)
Smith I, Abusetah Y, Osman H, Garg A*, Grant A, Lochmuller H, McMillan H, Pfeffer G, Korngut L, Gagnon C, Lintern S, Wojtal D, Selby K, Thavorn K, Warman-Chardon J. Assessing the Socio-Economic Burden of Inherited and Inflammatory Neuromuscular Diseases (BIND Study): A Study Protocol. Orphanet Journal of Rare Diseases. 2025; 20(1):404. Available from: 10.1186/s13023-025-03904-z. Impact Factor [3.4]. [Co-FA/Co-SA].
Grant A, Smith IC, Lola LER, Osman H, Hanns L, McMillan H, Pfeffer G, Kornkut L, Gagnon C, Lintern S, Selby K, Thavorn K, Warman-Chardon J. Unveiling the Financial Burden in 1,426 People Affected by Neuromuscular Diseases: Insights from the BIND Study. Neurology. 2025; 105(5):e213982. Available from: 10.1212/WNL.0000000000213982.Impact Factor [8.4] [Co-FA/Co-SA]
Kwok C, Thavorn K, Amjadi K, Aaron SD, Kendzerska T. Mortality after treatment of malignant pleural effusions with indwelling pleural catheters versus chemical pleurodesis: A population-based study. Respiratory Research. 2024; 25 (409). Available from: 10.1186/s12931-024-03023-6. Impact Factor [4.7]. (Trainee Publication). [Co-SA/CA].
Agarwal A, Kekre N, Atkins H, Imsirovic H, Hutton B, Coyle D, Thavorn K. Phase-based and lifetime health system costs for leukemia and lymphoma care: a population-based descriptive study. Current Oncology. 2024; 31(8):4192-4208. Available from: 10.3390/curroncol31080313. Impact Factor [2.8]. (Trainee Publication) [SA/CA].
Nochaiwong S, Chuamanochan M, Ruengorn C, Awiphan R, Bernstein JA, Thavorn K. Cost and Cost-Effectiveness of the Management Strategies of Chronic Urticaria: A Systematic Review. JAMA Dermatology. 2024; 160;(11):1225-1236. Available from: 10.1001/jamadermatol.2024.2863. Impact Factor [11.5]. [SA/CA].
[updated 2025-11-10]
Publications
Cost-effectiveness of chimeric antigen receptor T-cell therapy for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis
2025-12-31 Go to publicationPrevalence and predictors of potentially inappropriate prescribing using codified STOPP-START and Beers criteria: a retrospective cohort study in Ontario's older population
2025-11-01 Go to publicationEvolving landscape of economic evaluations of HIV pre‐exposure prophylaxis and pre‐exposure prophylaxis implementation strategies: a systematic review
2025-11-01 Go to publicationAssociation Between Peritoneal Dialysis-Associated Peritonitis and the Risk of All-Cause Mortality and Cardiovascular Death: A Time-Matched Retrospective Cohort Study
2025-10-30 Go to publicationEconomic evaluation of hospital-to-home transition interventions: a rapid review protocol
2025-05-07 Go to publicationEvolving landscape of economic evaluations of HIV pre-exposure prophylaxis and pre-exposure prophylaxis implementation strategies: A systematic review
2024-12-03 Go to publicationPsychometric evaluation of the multidimensional Uraemic Pruritus in Dialysis patients (UP-Dial) scale: comparison of haemodialysis and peritoneal dialysis patients with chronic pruritus
2024-08-14 Go to publicationTemporal and external validation of the multidimensional scale—uremic pruritus in dialysis patients (UP‐Dial): A psychometric evaluation
2024-08-01 Go to publicationPhase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive Study
2024-07-25 Go to publicationA systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders
2024-06-01 Go to publicationResource Use and Costs of Indwelling Pleural Catheters versus Pleurodesis for Malignant Pleural Effusions: A Population-based Study
2024-06-01 Go to publicationDevelopment of a survey to support assessment of safety learning systems
2024-06-01 Go to publication